1. Home
  2. Companies
  3. i&i Biotech Fund
IB

i&i Biotech Fund

About

We invest in innovative early stage Life Sciences startups that address unmet needs with novel discoveries backed by strong science and competitive advantage over current options.

We like to partner with founders creating breakthrough businesses in technology and healthcare. We are interested in start-ups with a unique selling point and global potential.

Our focus

  • Drug discovery
  • Medtech
  • Diagnostics
  • Other life sciences
  • AI in life sciences

Investment

We are happy to help you start your business from the very beginning.

It is never too early for us to meet you. We approach each project individually, but our preferred option is to act as co-investor.

  • Seed: Ready to create? We can start at € 150 K to support business creation.
  • Series A: Ready to grow? Our sweet spot lies between € 0.5 M and € 2 M.
  • Series B: Being exceptional? We keep a possibility of extra funding for our unicorn portfolio.

Where we invest

We focus mainly on Central and Eastern Europe. However, we are open to working with ambitious teams from other regions.

What we offer

  • Team: Our team is made up of Life Science and investment professionals with years of relevant experience. We work closely with our expert partners from i&i Prague and IOCB Tech. We are ready to help if needed.
  • Testing: We have a network of partners who evaluate and, in some cases, test technologies. We can provide valuable feedback or even confirmation of effectiveness by independent experts in the R&D field.
  • Partnership: We value partnerships with our network of investors and potential exit partners. We believe that it is advantageous for start-ups to meet such partners at the beginning of their journey to success. We can open the door for you.

Similar companies

DI

Debiopharm Innovation Fund

Debiopharm invests in Smart Data & Digital Health companies developing technologies that are applicable in the areas of oncology or infectious diseases.

RV

ROI VENTURES

We are angel investors and invest in B2B-focused, technology-driven, early-stage startups in Europe.

UP

UVC Partners

We partner with B2B startups across Europe at their earliest stages up to Series A. We initially invest €500,000 to €10 million, but we don't stop there.

BC

Biovance Capital

Investing in disruptive, early-stage biopharma companies across Europe.

IC

Impetus Capital

We’re an early stage venture capital fund partnering with founders at Seed and Series A stage.

EL

Elaia

European venture capital firm focused on digital & deep tech startups, from early stage to growth development.